Format

Send to

Choose Destination
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D92-9. doi: 10.1016/j.jacc.2013.10.024.

Chronic thromboembolic pulmonary hypertension.

Author information

1
University of California San Diego, La Jolla, California. Electronic address: h33kim@ucsd.edu.
2
Pneumology Department, University Hospitals of Leuven, Leuven, Belgium.
3
Cardiothoracic Surgery, Papworth Hospital, Cambridge, United Kingdom.
4
Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts.
5
Cardiothoracic Surgery, Paris-Sud University, Le Plessis Robinson, France.
6
Charles University, Prague, Czech Republic.
7
Cardiology, Medical University of Vienna, Vienna, Austria.
8
University of California San Diego, La Jolla, California.
9
Cardiac Surgery, Tokyo Medical University, Tokyo, Japan.
10
Cardiac, Thoracic, and Vascular Sciences, University of Padova, Padova, Italy.
11
Thoracic Surgery, Kerckhoff-Klinik, Bad Nauheim, Germany.

Abstract

Since the last World Symposium on Pulmonary Hypertension in 2008, we have witnessed numerous and exciting developments in chronic thromboembolic pulmonary hypertension (CTEPH). Emerging clinical data and advances in technology have led to reinforcing and updated guidance on diagnostic approaches to pulmonary hypertension, guidelines that we hope will lead to better recognition and more timely diagnosis of CTEPH. We have new data on treatment practices across international boundaries as well as long-term outcomes for CTEPH patients treated with or without pulmonary endarterectomy. Furthermore, we have expanded data on alternative treatment options for select CTEPH patients, including data from multiple clinical trials of medical therapy, including 1 recent pivotal trial, and compelling case series of percutaneous pulmonary angioplasty. Lastly, we have garnered more experience, and on a larger international scale, with pulmonary endarterectomy, which is the treatment of choice for operable CTEPH. This report overviews and highlights these important interval developments as deliberated among our task force of CTEPH experts and presented at the 2013 World Symposium on Pulmonary Hypertension in Nice, France.

KEYWORDS:

ACP; CT; CTEPH; CTPA; DHCA; ECMO; MRI; PAH; PAP; PEA; PH; PTPA; PVR; RCTs; VQ; antegrade cerebral perfusion; chronic thromboembolic pulmonary hypertension; computed tomography; computed tomography pulmonary angiogram; deep hypothermic circulatory arrest; extracorporeal membrane oxygenation; magnetic resonance imaging; percutaneous transluminal pulmonary angioplasty; pulmonary angiogram; pulmonary arterial hypertension; pulmonary artery pressure; pulmonary endarterectomy; pulmonary hypertension; pulmonary vascular resistance; randomized controlled trials; ventilation/perfusion; ventilation/perfusion scan

Republished in

PMID:
24355646
DOI:
10.1016/j.jacc.2013.10.024
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center